119 related articles for article (PubMed ID: 15015638)
1. Construction of antisense RNA expression plasmid for u-PAR and its transfection to highly invasive PC-3M cell subclones.
Liao G; Li Q; Feng Y; Deng Y; Li Z; Gong F; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(4):369-72. PubMed ID: 15015638
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of an antisense u-PAR vector on invasion of highly invasive human prostate carcinoma PC-3M cell subclones.
Liao G; Li Q; Feng Y; Deng Y; Li Z; Gong F; Ma D
J Huazhong Univ Sci Technolog Med Sci; 2003; 23(2):101-4. PubMed ID: 12973920
[TBL] [Abstract][Full Text] [Related]
3. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
Tavian D; Salvi A; De Petro G; Barlati S
Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
[TBL] [Abstract][Full Text] [Related]
4. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients.
Fibbi G; Barletta E; Dini G; Del Rosso A; Pucci M; Cerletti M; Del Rosso M
Lab Invest; 2001 Jan; 81(1):27-39. PubMed ID: 11204271
[TBL] [Abstract][Full Text] [Related]
5. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
6. [Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer].
Fang J; Wei WN; Xia LH; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2004 Mar; 25(3):143-6. PubMed ID: 15182581
[TBL] [Abstract][Full Text] [Related]
7. Urokinase (u-PA) and the u-PA receptor. Modulation of in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynold LM
Adv Exp Med Biol; 1999; 462():399-412. PubMed ID: 10599442
[TBL] [Abstract][Full Text] [Related]
8. [Screening of phosphoprotein associated with glycosphingolipid microdomains 1 (PAG1) by cDNA microarray and influence of overexpression of PAG1 on biologic behavior of human metastatic prostatic cancer cell line in vitro].
Yu WJ; Wang YW; Xie ZG; You JF; Wang JL; Cui XL; Pei F; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Feb; 39(2):88-94. PubMed ID: 20388373
[TBL] [Abstract][Full Text] [Related]
9. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
10. Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
Morrissey D; O'Connell J; Lynch D; O'Sullivan GC; Shanahan F; Collins JK
Clin Exp Metastasis; 1999 Feb; 17(1):77-85. PubMed ID: 10390151
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of expression of RhoC with invasiveness of prostate cancer cell line PC-3M in vitro].
Yuan Z; Su J; You JF; Wang JL; Cui XL; Zheng J
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):51-5. PubMed ID: 18346381
[TBL] [Abstract][Full Text] [Related]
12. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells.
Mohan PM; Lakka SS; Mohanam S; Kin Y; Sawaya R; Kyritsis AP; Nicolson GL; Rao JS
Clin Exp Metastasis; 1999; 17(7):617-21. PubMed ID: 10845561
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
Chung HW; Wen Y; Ahn JJ; Moon HS; Polan ML
J Clin Endocrinol Metab; 2001 Mar; 86(3):1332-40. PubMed ID: 11238529
[TBL] [Abstract][Full Text] [Related]
16. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
Haeckel C; Krueger S; Roessner A
Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA urokinase silencing inhibits invasion and migration of human hepatocellular carcinoma cells.
Salvi A; Arici B; De Petro G; Barlati S
Mol Cancer Ther; 2004 Jun; 3(6):671-8. PubMed ID: 15210852
[TBL] [Abstract][Full Text] [Related]
18. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
[TBL] [Abstract][Full Text] [Related]
19. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
Kook YH; Adamski J; Zelent A; Ossowski L
EMBO J; 1994 Sep; 13(17):3983-91. PubMed ID: 8076594
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
